Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 91
Selected: 0
NCT IDTitle
NCT05460234RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients
NCT03957187Prevalence and Clinical Associates of Iron Deficiency in Patients With Atrial Fibrillation
NCT01438359A Drug-Drug Interaction Study of Furosemide and PA21
NCT04817670Study to Assess Efficacy and Safety of VIT-2763 (Vamifeport) in Subjects With Sickle Cell Disease
NCT03759964Effects of Ferinject® on Anemia and Transfusion Rates After Cardiac Surgery
NCT01477411A Drug-Drug Interaction Study of Digoxin and PA21
NCT01100879Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy
NCT04903717Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists
NCT03071263Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
NCT01057004EVIdence Based TreAtment - Heart Failure (EVITA-HF)
NCT00824460Study of Phosphate Levels in Patients With Chronic Kidney Disease
NCT01975272The Use of Iron Therapy for Patients With Anemia After Caesarean Section
NCT00810004Maintenance Treatment of Iron Deficiency in IBD Patients
NCT02937454Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency
NCT04364269Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia
NCT00706667Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery
NCT05524467Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients
NCT06256991Potassium Correction for RAAS Optimization in Chronic Kidney Disease
NCT05415969CKD-aP Among Adults on Dialysis in Switzerland
NCT01464190A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients
NCT02243735Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia
NCT02694744Patiromer With or Without Food for the Treatment of Hyperkalemia
NCT05034250Iron Status in Female Infertility and Recurrent Miscarriage
NCT02213653Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency
NCT00994318Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
NCT03781089Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients
NCT01345968Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery
NCT04616092Effect of Preoperative Intravenous Ferric Carboxymaltose for Clipping Surgery
NCT00882414Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)
NCT05389826mHealth for Phosphorus Management in CKD.
NCT01371747Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)
NCT01810939A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL)
NCT03591406To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia
NCT01131624Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
NCT04806048Feasibility of Implementation of Recommended Standards in Patients With Heart Failure
NCT00414128Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis
NCT02232906Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD)
NCT03574311Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery
NCT01913808Comparing Intravenous and Oral Iron in Postoperative Anemia
NCT01453608A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency
NCT01219309Omega-3/Omega-6 Fatty Acids for Attention-Deficit/Hyperactivity Disorder (ADHD): A Trial in Children and Adolescents
NCT04249648Hyperkalaemia and Its Impact on Therapy with RAASi
NCT01820949Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients
NCT04510792IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors
NCT05885737Phase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus
NCT01110356Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Bearing Age
NCT03769441Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation
NCT01477424A Drug-Drug Interaction Study of Warfarin and PA21
NCT03047954Broncho-Vaxom (OM 85 BV) in Children Suffering From Atopic Dermatitis
NCT02147795The German Patient Blood Management Network